Clinical trial evaluates heterologous prime/boost regimens in preventative HIV vaccination
Almost 40 million people worldwide live with HIV/AIDS, with an estimated 2.5 million new cases per year. Therefore, there has been a large global effort to develop an effective vaccine against the virus. HIV-1 vaccine development ...
Oct 1, 2014
0
0